Parekh T, Pemmasani S, Desai R. Marijuana use among young adults (18-44 years of age) and risk of stroke: a Behavioral Risk Factor Surveillance System Survey analysis. Stroke. 2020;51:308 310. doi: 180. Cam J, Farr M. Drug addiction. N Engl J Med. 2003;349:975 986. doi: 181. Herbeck DM, Hser YI, Teruya C. Empirically supported substance abuse treat- ment approaches: a survey of treatment providers perspectives and prac- tices. Addict Behav. 2008;33:699 712. doi: 10.1016/j.addbeh.2007.12.003 182. World Health Organization. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. World Health Organization; 2009. 183. Edjoc RK, Reid RD, Sharma M. The effectiveness of smoking cessation in- terventions in smokers with cerebrovascular disease: a systematic review. BMJ Open. 2012;2:e002022. doi: 10.1136/bmjopen-2012-002022 184. Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J. 2013;34:268 277. doi: 185. Zonneveld TP, Richard E, Vergouwen MD, Nederkoorn PJ, de Haan R, Roos YB, Kruyt ND. Blood pressure-lowering treatment for preventing recur- rent stroke, major vascular events, and dementia in patients with a his- tory of stroke or transient ischaemic attack. Cochrane Database Syst Rev. 186. PROGRESS Collaborative Group. Randomised trial of perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033 1041. doi: 187. Schrader J, L ders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC; MOSES Study Group. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective random- ized controlled study (MOSES). Stroke. 2005;36:1218 1226. doi: 188. 